Certified by Founder Lodge
Alzheon, Inc. | Preserving Future Memories
United States - Framingham, MA
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimer’s clinical candida
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 14 ,2024 | Series E | $100,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Distribusion Technologies | $80,000,000 | (Sep 27, 2024)
Quorum | Undisclosed Amount | (Sep 27, 2024)
Convergence | $12,000,000 | (Sep 27, 2024)
Tetrix | $5,000,000 | (Sep 27, 2024)
AmpUp | $15,000,000 | (Sep 27, 2024)
